Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for USA stock SUPN Supernus Pharmaceuticals. Dated: 15 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 50.11 and Closed at: 49.94, which is -0.34% of previous session's close. It moved within a range of 49.48 and 50.91
The session was a Bearish session with an average volume of 349000, which is -31.81% of previous session's volumes.
- There is some negative change in the short term trend, but its too soon to jump onto conclusions.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 6 days back on short term averages
Support for tomorrow is 49 and resistance for tomorrow is 50.43
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 49.31, 48.68 resistance for tomorrow's hourly charts is 50.74, 51.54
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.72 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.24 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 51.27 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 49.85 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 46.61 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 50.24 and 200 DMA is at 46.61, while 50 DMA and 100 DMA are at 51.27 and 49.85 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 50.24 and 20 EMA is at 50.68
| Date | Closing Price | 20 SMA | 20 EMA |
| 15 Wed Apr | 49.94 | 50.24 | 50.68 |
| 14 Tue Apr | 50.11 | 50.25 | 50.76 |
| 13 Mon Apr | 49.95 | 50.24 | 50.83 |
| 10 Fri Apr | 50.68 | 50.27 | 50.92 |
| 09 Thu Apr | 51.50 | 50.39 | 50.95 |
| 08 Wed Apr | 51.61 | 50.53 | 50.89 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 51.27 and 50 EMA is at 50.78
| Date | Closing Price | 50 SMA | 50 EMA |
| 15 Wed Apr | 49.94 | 51.27 | 50.78 |
| 14 Tue Apr | 50.11 | 51.24 | 50.81 |
| 13 Mon Apr | 49.95 | 51.21 | 50.84 |
| 10 Fri Apr | 50.68 | 51.19 | 50.88 |
| 09 Thu Apr | 51.50 | 51.17 | 50.89 |
| 08 Wed Apr | 51.61 | 51.12 | 50.87 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 49.85 and 100 EMA is at 49.76
| Date | Closing Price | 100 SMA | 100 EMA |
| 15 Wed Apr | 49.94 | 49.85 | 49.76 |
| 14 Tue Apr | 50.11 | 49.8 | 49.76 |
| 13 Mon Apr | 49.95 | 49.75 | 49.75 |
| 10 Fri Apr | 50.68 | 49.69 | 49.75 |
| 09 Thu Apr | 51.50 | 49.63 | 49.73 |
| 08 Wed Apr | 51.61 | 49.58 | 49.69 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 46.61 and 200 EMA is at 46.85
| Date | Closing Price | 200 SMA | 200 EMA |
| 15 Wed Apr | 49.94 | 46.61 | 46.85 |
| 14 Tue Apr | 50.11 | 46.51 | 46.82 |
| 13 Mon Apr | 49.95 | 46.42 | 46.79 |
| 10 Fri Apr | 50.68 | 46.33 | 46.76 |
| 09 Thu Apr | 51.50 | 46.23 | 46.72 |
| 08 Wed Apr | 51.61 | 46.14 | 46.67 |
Supernus Pharmaceuticals has performed better than Novartis Ag in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Laboratory Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Laboratory Corporation, about 0.29% more returns!
Iqvia Holdings has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Iqvia Holdings, about 7.47% more returns!
Humana Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Humana Inc, about 17.77% more returns!
Sol Gel has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Sol Gel, about 1.79% more returns!
Ovid Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 39.04% more returns!
Orthofix Medical has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Orthofix Medical, about 8.71% more returns!
Irhythm Technologies has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Irhythm Technologies, about 7.58% more returns!
Supernus Pharmaceuticals has performed better than Iradimed Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Incyte Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 4.79% more returns!
Supernus Pharmaceuticals has performed better than Galapagos Nv in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Ensign Group in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Cumberland Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 8.04% more returns!
Biomarin Pharmaceutical has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 0.34% more returns!
Aurinia Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 12.65% more returns!
Supernus Pharmaceuticals has performed better than Arvinas Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Alkermes Plc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Alkermes Plc, about 21.87% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term and the sell signal is strong.
Supernus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.83 and Supernus Pharmaceuticals SUPN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
